Asian Subjects With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy

Clinical trial NCT01584830 · COMPLETED

Trial details

NCT number: NCT01584830
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Colorectal Neoplasms

Start date: 2012-04-01
Primary completion: 2013-11-01
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.